Anti-alpha-enolase antibodies in patients with inflammatory Bowel disease.
about
Autoimmune retinopathyAutoantibodies in primary sclerosing cholangitisGastrointestinal Behçet's disease: a reviewSeroreactivity against glycolytic enzymes in inflammatory bowel disease.B Cell Anomalies in Autoimmune Retinopathy (AIR)Primary biliary cirrhosis: what do autoantibodies tell us?Comparative analysis of inflamed and non-inflamed colon biopsies reveals strong proteomic inflammation profile in patients with ulcerative colitis.Proteomic analysis of colonic mucosal tissue from tuberculous and ulcerative colitis patients.Anti-α-enolase Antibodies in Serum from Pediatric Patients Affected by Inflammatory Diseases: Diagnostic and Pathogenetic Insights.Soluble alpha-enolase activates monocytes by CD14-dependent TLR4 signalling pathway and exhibits a dual function.Neuron specific enolase: a promising therapeutic target in acute spinal cord injury.The enigma of autoimmune retinopathy.α-Enolase, a multifunctional protein: its role on pathophysiological situationsDisruption of HLA class II antigen presentation in Burkitt lymphoma: implication of a 47,000 MW acid labile protein in CD4+ T-cell recognition.Proteome profiling of spinal cord and dorsal root ganglia in rats with trinitrobenzene sulfonic acid-induced colitis.Antibiotics and probiotics in chronic pouchitis: a comparative proteomic approach.Targeting Enolase in Reducing Secondary Damage in Acute Spinal Cord Injury in Rats.Autoimmune Retinopathy: Current Concepts and Practices (An American Ophthalmological Society Thesis).Autoimmune retinopathy and optic neuropathy associated with enolase-positive renal oncocytoma
P2860
Q27027058-CFEF8757-30DB-4303-BBEE-D5AACA839F79Q27489093-1B62C5F1-2C96-45EC-8580-78ABCDA6DA89Q28084556-C887F88D-1D6B-4A73-B59B-9BE311EA354EQ33632430-23ED9C07-D078-4C0A-919E-2A893477DE0DQ33917237-B61236E2-5A5D-49FD-B812-3778802B299CQ34041388-2CDE3ADE-245C-426E-AF5C-81B2A0B2A79BQ34314918-1BD36881-1150-4E8F-9B2E-32D6256181E1Q34339382-DB9961D7-4414-40F3-B511-2DA985A91AC4Q35295014-F7057C2A-6361-4A5E-A310-C5559F7DE1EBQ36776946-AE098A74-E371-4218-8E5E-A7FA15F12E73Q36892833-A491F795-9E6A-4623-A10A-070DEAC9E856Q37088449-F0CB1D79-67DA-4E04-82DF-1320DE2471EDQ38057216-B5C750F8-9495-4232-9B03-C79290B6C9CFQ39015659-59D60BA2-750F-4A0A-80FB-675538AB2C28Q41928668-A2C5559E-2023-4CAC-8C96-3F6CD1CD6070Q42945261-5537F416-EB35-4C48-8A84-954825025852Q47885151-DF23D15A-936F-4559-A05E-2BD6AC60BB7EQ54968656-E4A3626E-7739-4495-91DE-33E881584134Q58754086-5CA26C09-722A-4D3D-A8F9-22AFF0280738
P2860
Anti-alpha-enolase antibodies in patients with inflammatory Bowel disease.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Anti-alpha-enolase antibodies in patients with inflammatory Bowel disease.
@en
type
label
Anti-alpha-enolase antibodies in patients with inflammatory Bowel disease.
@en
prefLabel
Anti-alpha-enolase antibodies in patients with inflammatory Bowel disease.
@en
P2093
P50
P1433
P1476
Anti-alpha-enolase antibodies in patients with inflammatory Bowel disease
@en
P2093
Frans Schuit
Georges Michiels
Karolien Van den Bergh
Leentje Van Lommel
Paul Rutgeerts
Sofie Joossens
Stefan Clerens
Xavier Bossuyt
P304
P356
10.1373/CLINCHEM.2007.098368
P407
P577
2008-01-24T00:00:00Z